Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Arc-1 vs Rebody Health

Arc-1 and Rebody Health both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
Arc-1 logo

Arc-1

7.5
★★★★☆3.8/5

Best for: compounded semaglutide at $199.99/month

Visit Arc-1 →
VS
Rebody Health logo

Rebody Health

9.0
★★★★★4.5/5

Best for: semaglutide from $420.99/month

Visit Rebody Health →

If you are choosing between Arc-1 and Rebody Health, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Rebody Health leads our six-part score, 9.0 to 7.5.

Arc-1 vs Rebody Health price

Arc-1 and Rebody Health start at the same figure, $199.99 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.

Drug by drug: Semaglutide costs the same at both, $199.99 a month; tirzepatide is cheaper at Arc-1 ($199.99 a month vs $249.99 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format, Arc-1 prices compounded injections, while Rebody Health prices compounded injections and brand-name pens.

If you want the FDA-approved brand rather than a compounded version, Rebody Health is the only one of the two with a brand-name price.

Where each one treats patients

Arc-1 does not publish where it ships, and Rebody Health lists 47 states.

Pricing

Arc-1

Compounded Semaglutide 0.5mgCompounded
$199.99/mo
semaglutide
Compounded Semaglutide 1mgCompounded
$249.99/mo
semaglutide
Compounded Semaglutide 2.5mgCompounded
$549.99/mo
semaglutide
Compounded Tirzepatide 2.5mgCompounded
$199.99/mo
tirzepatide
Compounded Tirzepatide 5mgCompounded
$249.99/mo
tirzepatide
Compounded Tirzepatide 7.5mgCompounded
$399.99/mo
tirzepatide

Rebody Health

StartingCompounded
$199.99/mo
semaglutide

Weekly compounded injection from $199.99/mo, dose-scaled higher as the prescription increases; daily oral 'melt' semaglutide from $143.99/mo. $50 off first month.

StartingCompounded
$249.99/mo
tirzepatide

Weekly compounded injection from $249.99/mo, dose-scaled higher as the prescription increases; daily oral 'melt' tirzepatide from $249.99/mo.

BrandBrand-name
$420.99/mo
semaglutide

Brand Wegovy weekly pen from $420.99/mo; Wegovy oral tablets from $343.99/mo.

BrandBrand-name
$573.99/mo
tirzepatide

Brand Zepbound KwikPen from $573.99/mo.

What each price covers

Both prices cover the clinician visit and the medication itself.

Arc-1's price also covers shipping, which Rebody Health does not claim.

Arc-1 is silent on lab work and coaching.

Rebody Health is silent on shipping, lab work and coaching.

Arc-1

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Rebody Health

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

Not stated

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, Rebody Health scores 9.0 and Arc-1 7.5 out of 10.

Arc-1 is stronger on support (7.0 vs 5.5).

Rebody Health is stronger on value (10.0 vs 6.6), trust & safety (8.5 vs 6.5) and accessibility (9.5 vs 5.0).

Effectiveness and user experience are within half a point.

How we score

Arc-1

7.5/10

Overall

Rebody Health

9.0/10

Value25%

6.6A
vs
B
10.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

6.5A
vs
B
8.5

Accessibility10%

5.0A
vs
B
9.5

Support10%

7.0A
vs
B
5.5

FDA warning letters

Neither Arc-1 nor Rebody Health has an FDA warning letter on record with us.

Features & Coverage

FeatureArc-1Rebody Health
Starting Price$199.99/mo$199.99/mo
Features3 features✓8 features
States AvailableNot disclosed47
Compounded✓ Yes✓ Yes
Brand Name—✓ Yes
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About Arc-1

Arc-1 does not bill monthly. Doses get bought one at a time: compounded semaglutide from $249.99, compounded tirzepatide from $299.99. The rest of this longevity-focused catalog runs to metformin, sermorelin, rapamycin, NAD+, B12, and ED medication.

Read our full Arc-1 review →

About Rebody Health

Prices are published up front: compounded semaglutide from about $199.99/mo and compounded tirzepatide from about $249.99/mo as weekly injections, with daily oral melt tablets and brand-name Wegovy and Zepbound also sold, and dose-based pricing shown before each refill. Compound Technologies Inc. operates the brand in 47 states, excluding Massachusetts, Rhode Island and Vermont. Rebody is not a pharmacy, and the licensed compounding pharmacies that prepare its prescriptions are not named on the site.

Read our full Rebody Health review →

Pros & Cons

Arc-1

What we like

  • Semaglutide costs $199.99 a month, close to the $185 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $199.99 a month, 20% below the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits and shipping
  • We found no FDA warning letters issued to Arc-1

Watch-outs

  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Rebody Health

What we like

  • Semaglutide costs $420.99 a month, 58% below the $997 median for brand-name semaglutide across the sellers we compare
  • Tirzepatide costs $573.99 a month, 54% below the $1249 median for brand-name tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication and clinician visits
  • Serves 47 states
  • We found no FDA warning letters issued to Rebody Health

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Rebody Health

Rebody Health wins this one, 9.0 to 7.5, above all for semaglutide from $420.99/month. Arc-1 fits better if compounded semaglutide at $199.99/month is your priority.

Choose Arc-1 if…

You want compounded semaglutide at $199.99/month and an opening price near $199.99 a month.

Choose Rebody Health if…

You want semaglutide from $420.99/month and an opening price near $199.99 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

8.4

Strut Health

Semaglutide at $99/month, 48% below the typical price

8.4

Enhance MD

Knowing which pharmacy fills the vial: it names Tru Meds Rx

6.1

DudeMeds

Compounded semaglutide at $175/month

Arc-1 vs Rebody Health: FAQ

Neither on the entry price: Arc-1 and Rebody Health both start at about $200 a month. The difference is in what the price includes.
Yes, both sell semaglutide and tirzepatide.
Arc-1 does not publish where it ships; Rebody Health lists 47 states. Confirm your state before paying.
Both include the clinician visit and the medication itself. Only Arc-1 includes shipping.
Arc-1 has none. Rebody Health has none.
No. Neither Arc-1 nor Rebody Health pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.